Counterpath (CPAH) Swings to Q1 Profit of 1c/Share

Counterpath (NASDAQ: CPAH) reported Q1 EPS of $0.01, versus ($0.03) reported last year. Revenue for the quarter came in at $4.39 million, versus $2.76 million reported last year.

For earnings history and earnings-related data on Counterpath (CPAH) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Nebius Group (NBIS) PT Raised to $300 at Compass Point
• McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance